Literature DB >> 17238200

Anisotropic surface chemistry of aspirin crystals.

Jerry Y Y Heng1, Alexander Bismarck, Adam F Lee, Karen Wilson, Daryl R Williams.   

Abstract

The wettability of the (001), (100), and (011) crystallographic facets of macroscopic aspirin crystals has been experimentally investigated using a sessile drop contact angle (theta) method. theta for a nonpolar liquid was very similar for all three facets, though significant theta differences were observed for three polar probe liquids. The observed hydrophobicity of the (001) and (100) facets is ascribed to a reduced hydrogen bonding potential at these surfaces, whilst the observed hydrophilicity of facet (011) may be attributed to presence of surface carboxylic functionalities as confirmed by X-ray photoelectron spectroscopy (XPS). The dispersive component of the surface free energy (gamma(s)(d)) was similar for all three facets (35 +/- 2 mJ/m2). The total surface energy, gammas varied between 46 and 60 mJ/m2 due to significant variations in the polar/acid-base components of gamma for all facets. Surface polarity as determined by gamma measurements and XPS data were in good agreement, linking the variations in wettability to the concentration of oxygen containing surface functional groups. In conclusion, the wettability and the surface energy of a crystalline organic solid, such as aspirin, was found to be anisotropic and facet dependant, and in this case, related to the presence of surface carboxylic functionalities. (c) 2007 Wiley-Liss, Inc. and the American Pharmacists Association.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17238200     DOI: 10.1002/jps.20841

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  9 in total

1.  Anisotropic surface chemistry of crystalline pharmaceutical solids.

Authors:  Jerry Y Y Heng; Alexander Bismarck; Daryl R Williams
Journal:  AAPS PharmSciTech       Date:  2006-10-06       Impact factor: 3.246

2.  The Effect of Polymorphism on Surface Energetics of D-Mannitol Polymorphs.

Authors:  Robert R Smith; Umang V Shah; Jose V Parambil; Daniel J Burnett; Frank Thielmann; Jerry Y Y Heng
Journal:  AAPS J       Date:  2016-09-08       Impact factor: 4.009

Review 3.  Microstructure of Tablet-Pharmaceutical Significance, Assessment, and Engineering.

Authors:  Changquan Calvin Sun
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.200

4.  Τhe role of surface energy in the apparent solubility of two different calcite crystal habits.

Authors:  Eftychios Hadjittofis; Silvia M Vargas; James D Litster; Kyra L Sedransk Campbell
Journal:  Proc Math Phys Eng Sci       Date:  2021-08-25       Impact factor: 2.704

5.  Decoupling the contribution of surface energy and surface area on the cohesion of pharmaceutical powders.

Authors:  Umang V Shah; Dolapo Olusanmi; Ajit S Narang; Munir A Hussain; Michael J Tobyn; Steve J Hinder; Jerry Y Y Heng
Journal:  Pharm Res       Date:  2014-07-19       Impact factor: 4.200

6.  Molecular basis of crystal morphology-dependent adhesion behavior of mefenamic acid during tableting.

Authors:  Vrushali Waknis; Elza Chu; Roxana Schlam; Alexander Sidorenko; Sherif Badawy; Shawn Yin; Ajit S Narang
Journal:  Pharm Res       Date:  2013-08-14       Impact factor: 4.200

7.  On the origin of surface imposed anisotropic growth of salicylic and acetylsalicylic acids crystals during droplet evaporation.

Authors:  Maciej Przybyłek; Piotr Cysewski; Maciej Pawelec; Dorota Ziółkowska; Mirosław Kobierski
Journal:  J Mol Model       Date:  2015-02-19       Impact factor: 1.810

Review 8.  Particle engineering in pharmaceutical solids processing: surface energy considerations.

Authors:  Daryl R Williams
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 9.  Influences of Crystal Anisotropy in Pharmaceutical Process Development.

Authors:  Eftychios Hadjittofis; Mark Antonin Isbell; Vikram Karde; Sophia Varghese; Chinmay Ghoroi; Jerry Y Y Heng
Journal:  Pharm Res       Date:  2018-03-19       Impact factor: 4.200

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.